360 related articles for article (PubMed ID: 30390758)
1. Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.
Chodon T; Lugade AA; Battaglia S; Odunsi K
Hematol Oncol Clin North Am; 2018 Dec; 32(6):1025-1039. PubMed ID: 30390758
[TBL] [Abstract][Full Text] [Related]
2. Basics of immunotherapy for epithelial ovarian cancer.
Bund V; Azaïs H; Bibi-Triki S; Lecointre L; Betrian SB; Angeles MA; Eberst L; Faller E; Boisramé T; Bendifallah S; Akladios C; Deluche É;
J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102283. PubMed ID: 34875397
[TBL] [Abstract][Full Text] [Related]
3. Active Immunotherapy of Cancer.
Chodon T; Koya RC; Odunsi K
Immunol Invest; 2015; 44(8):817-36. PubMed ID: 26575466
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy.
Huang C; Li H; Feng Y; Li X; Zhang Z; Jiang C; Wang J; Yang C; Fu Y; Mu M; Zhao S; Wang Z; Kuang Y; Hou H; Wang Y; Guo W; Xu J; Yang H; Zhou L; Tong A; Guo G
Theranostics; 2020; 10(23):10498-10512. PubMed ID: 32929362
[No Abstract] [Full Text] [Related]
5. Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses
Flores I; Hevia D; Tittarelli A; Soto D; Rojas-Sepúlveda D; Pereda C; Tempio F; Fuentes C; Falcón-Beas C; Gatica J; Falcón-Beas F; Galindo M; Salazar-Onfray F; González FE; López MN
J Immunol Res; 2019; 2019():9631515. PubMed ID: 31886313
[TBL] [Abstract][Full Text] [Related]
6. Emerging immunotherapies in ovarian cancer.
Ojalvo LS; Nichols PE; Jelovac D; Emens LA
Discov Med; 2015 Sep; 20(109):97-109. PubMed ID: 26463091
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in Ovarian Cancer.
Wang W; Liu JR; Zou W
Surg Oncol Clin N Am; 2019 Jul; 28(3):447-464. PubMed ID: 31079799
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in ovarian cancer.
Odunsi K
Ann Oncol; 2017 Nov; 28(suppl_8):viii1-viii7. PubMed ID: 29232467
[TBL] [Abstract][Full Text] [Related]
9. SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy.
Benard E; Casey NP; Inderberg EM; Wälchli S
Scand J Immunol; 2020 Oct; 92(4):e12917. PubMed ID: 32557659
[TBL] [Abstract][Full Text] [Related]
10. Immunity and immune suppression in human ovarian cancer.
Preston CC; Goode EL; Hartmann LC; Kalli KR; Knutson KL
Immunotherapy; 2011 Apr; 3(4):539-56. PubMed ID: 21463194
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.
Pereira M; Matuszewska K; Jamieson C; Petrik J
Front Endocrinol (Lausanne); 2021; 12():772349. PubMed ID: 34867818
[TBL] [Abstract][Full Text] [Related]
12. Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.
Wu J; Cai J
Dig Dis Sci; 2021 Feb; 66(2):359-368. PubMed ID: 32140943
[TBL] [Abstract][Full Text] [Related]
13. Immunology of tissue homeostasis, ovarian cancer growth and regression, and long lasting cancer immune prophylaxis - review of literature.
Bukovsky A
Histol Histopathol; 2021 Jan; 36(1):31-46. PubMed ID: 32896865
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophage-targeted therapeutics in ovarian cancer.
An Y; Yang Q
Int J Cancer; 2021 Jul; 149(1):21-30. PubMed ID: 33231290
[TBL] [Abstract][Full Text] [Related]
15. Emerging trends in the immunotherapy of pancreatic cancer.
Banerjee K; Kumar S; Ross KA; Gautam S; Poelaert B; Nasser MW; Aithal A; Bhatia R; Wannemuehler MJ; Narasimhan B; Solheim JC; Batra SK; Jain M
Cancer Lett; 2018 Mar; 417():35-46. PubMed ID: 29242097
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Cancer Immunotherapy: Turning up the Heat.
Ghisoni E; Imbimbo M; Zimmermann S; Valabrega G
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208030
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.
Santos JM; Heiniö C; Cervera-Carrascon V; Quixabeira DCA; Siurala M; Havunen R; Butzow R; Zafar S; de Gruijl T; Lassus H; Kanerva A; Hemminki A
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940588
[TBL] [Abstract][Full Text] [Related]
18. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in ovarian cancer.
Krishnan V; Berek JS; Dorigo O
Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
[TBL] [Abstract][Full Text] [Related]
20. Immune Therapy Opportunities in Ovarian Cancer.
Kandalaft LE; Odunsi K; Coukos G
Am Soc Clin Oncol Educ Book; 2020 May; 40():1-13. PubMed ID: 32412818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
